Citadel Advisors’s Adeptus Health Inc ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-10,000
Closed -$18K 8561
2017
Q1
$18K Buy
+10,000
New +$56.1K ﹤0.01% 7283
2016
Q4
Sell
-19,400
Closed -$835K 8279
2016
Q3
$835K Sell
19,400
-13,800
-42% -$623K ﹤0.01% 4067
2016
Q2
$1.72M Sell
33,200
-6,200
-16% -$372K ﹤0.01% 2902
2016
Q1
$2.19M Buy
39,400
+33,000
+516% +$1.71M ﹤0.01% 2549
2015
Q4
$349K Sell
6,400
-4,900
-43% -$313K ﹤0.01% 5006
2015
Q3
$913K Buy
+11,300
New +$1.17M ﹤0.01% 3938

Other funds holding ADPT

Citadel Advisors's ADPT Position: Q2 2017 in Review

Citadel Advisors sold out of Adeptus Health Inc (ADPT) in Q2 2017, closing a stake of 69,607 shares — an estimated $125K sold.

Citadel Advisors first reported a position in ADPT in Q4 2014 and held it in 10 quarters. The position peaked at $25.5M in Q3 2015. 9 funds tracked by Wall St. Rank hold ADPT as of Q2 2017.

  • Citadel Advisors reported no remaining Adeptus Health Inc position as of Q2 2017 after selling out during the quarter.
  • Citadel Advisors sold 69,607 Adeptus Health Inc shares in Q2 2017, an estimated $125K.
  • Citadel Advisors first reported a position in Adeptus Health Inc in Q4 2014 and held it in 10 quarters.
  • Citadel Advisors's Adeptus Health Inc position peaked at $25.5M in Q3 2015.
  • 9 funds tracked by Wall St. Rank held Adeptus Health Inc as of Q2 2017.

Based on Citadel Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.